MMP9 and neoplasm: A human pancreatic epithelioid carcinoma cell line, Panc I, with lower MMP-2 and MMP-9 expression levels than HT1080 cells was unable to activate the recombinant SeV [267], demonstrating this system as an efficient tool for delivery to tumor sites where MMP-2 and MMP-9 are overexpressed.